It is important to further improve the efficiency of hepatitis B core antigen-pulsed monocyte-derived dendritic cell (core-DC) vaccine in clinical immunotherapy for chronic hepatitis B virus (HBV) infection in humans. Our study shows that CpG-treated plasmacytoid dendritic cells (pDCs) can efficient...
Bibliographische Detailangaben
| Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 129(2008), 2 vom: 11. Nov., Seite 295-303
|
|---|
| 1. Verfasser: |
Chen, Weiwei
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Zhang, Zheng,
Shi, Ming,
Chen, Liangen,
Fu, Junliang,
Shi, Feng,
Zhang, Bing,
Zhang, Hui,
Jin, Lei,
Wang, Fu-Sheng |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2008
|
|---|
| Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.)
|
|---|
| Schlagworte: | Journal Article
Research Support, Non-U.S. Gov't
CPG-oligonucleotide
Hepatitis B Core Antigens
Interferon-alpha
Oligodeoxyribonucleotides
Tumor Necrosis Factor-alpha
Interferon-gamma
82115-62-6 |
|---|